Affinia Therapeutics is an innovative gene therapy company focused on broadening the reach of gene therapy. Our proprietary Affinia Rationally-designed Therapies (ART) platform is created to address key limitations of conventional gene therapies, by developing novel capsids, novel promoters, and novel manufacturing approaches to developing gene therapies for rare and prevalent devastating diseases. We are backed by a strong syndicate of life science investors and have ambitious plans to have a dramatic impact on the lives of patients around the world.
As an early employee you will play a key role in setting our culture and values. You will be working alongside the founding management team who have a track record of success in the industry. The pace of work is dynamic, fast and fun.
We offer competitive salary and benefits with the ability to make a difference.
Location: United States, Massachusetts, Waltham
Employees: 51-200
Total raised: $170M
Founded date: 2019
Investors 10
Funding Rounds 2
| Date | Series | Amount | Investors |
| 04.05.2021 | Series B | $110M | - |
| 01.04.2020 | Series A | $60M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 04.01.2022 | Gene therapy biotech Affinia Therapeutics files for a $100 m... | - | fprimecapi... |
| 14.12.2021 | Affinia Therapeutics Appoints Thomas Leggett as Chief Financ... | WALTHAM, Mass., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy c... | marketscre... |
| 08.09.2021 | Affinia Therapeutics Announces Indications for Lead Gene The... | Indications include metachromatic leukodystrophy, a rare, progressive, and fatal disease affecting t... | marketscre... |
| 04.05.2021 | Affinia Therapeutics secures $110M | Affinia Therapeutics has raised a $110 million Series B co-led by EcoR1 Capital and Farallon Capital... | pitchbook.... |
| 04.05.2021 | Affinia Therapeutics raises $110 million for gene therapy tr... | Affinia Therapeutics, a Waltham-based biotech working on gene therapies to treat diseases using tech... | statnews.c... |
| 03.05.2021 | Affinia Therapeutics Closes $110 Million Series B Financing | - | tcgcrossov... |
| 03.05.2021 | Affinia Therapeutics Closes $110 Million Series B Financing | Financing co-led by EcoR1 Capital and Farallon Capital Management Proceeds to support continued deve... | marketscre... |
| 03.05.2021 | Affinia Therapeutics Closes $110 Million Series B Financing | - | fprimecapi... |
| 01.04.2020 | Affinia Therapeutics Raises $60M in Series A Financing | Affinia Therapeutics, a Waltham, Mass.-based gene therapy company, closed a $60m Series A financing.... | finsmes.co... |
| 31.03.2020 | Affinia Therapeutics Scores $60M | WALTHAM, MA, Affinia Therapeutics today announced it has closed an oversubscribed $60 million Seri... | vcnewsdail... |
Show more